Matches in Wikidata for { <http://www.wikidata.org/entity/Q93531280> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q93531280 description "article scientifique publié en 1989" @default.
- Q93531280 description "wetenschappelijk artikel" @default.
- Q93531280 description "наукова стаття" @default.
- Q93531280 name "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 name "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 type Item @default.
- Q93531280 label "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 label "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 prefLabel "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 prefLabel "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 P1433 Q93531280-194DD839-F898-4C6C-852B-17150C81A370 @default.
- Q93531280 P1476 Q93531280-C28F9365-AE1D-4043-A3C6-9260260C78ED @default.
- Q93531280 P2093 Q93531280-1F91FD08-273E-4068-8738-BDD036418A7E @default.
- Q93531280 P2093 Q93531280-88E4DF9C-C246-495A-9539-41455A76BE13 @default.
- Q93531280 P2093 Q93531280-C962C46F-5263-4490-8F0B-1FC67CA49BDE @default.
- Q93531280 P2093 Q93531280-EFEC2CC9-D79F-4C43-8C46-E5AFF90229C9 @default.
- Q93531280 P304 Q93531280-5530D232-DBCC-453E-B5CD-682AB18DDCB7 @default.
- Q93531280 P31 Q93531280-44BEE314-07E9-4558-AA50-65131CAD3E6C @default.
- Q93531280 P356 Q93531280-A79AF1F1-9F61-4604-96D4-82CFD4570F2E @default.
- Q93531280 P433 Q93531280-1A15640F-854F-4B3F-A613-81988AFD0029 @default.
- Q93531280 P478 Q93531280-5E5E2082-BDAC-477C-9A1B-D8E5775E7FCE @default.
- Q93531280 P577 Q93531280-73075A46-C4E0-4F87-9806-492C66FB79C0 @default.
- Q93531280 P698 Q93531280-60A04FED-262B-4CE9-B900-F940B195F185 @default.
- Q93531280 P356 0024-3205(89)90017-9 @default.
- Q93531280 P698 2532697 @default.
- Q93531280 P1433 Q5256275 @default.
- Q93531280 P1476 "Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice" @default.
- Q93531280 P2093 "F B Weihmuller" @default.
- Q93531280 P2093 "J P Bruno" @default.
- Q93531280 P2093 "M Hadjiconstantinou" @default.
- Q93531280 P2093 "N H Neff" @default.
- Q93531280 P304 "2495-2502" @default.
- Q93531280 P31 Q13442814 @default.
- Q93531280 P356 "10.1016/0024-3205(89)90017-9" @default.
- Q93531280 P433 "25" @default.
- Q93531280 P478 "45" @default.
- Q93531280 P577 "1989-01-01T00:00:00Z" @default.
- Q93531280 P698 "2532697" @default.